Journal of Urology

Papers
(The TQCC of Journal of Urology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Urological Oncology: Bladder, Penis and Urethral Cancer, and Basic Principles of Oncology418
Urological Oncology: Prostate Cancer358
Editorial Comment324
This Month in Adult Urology307
Urological Oncology: Testis Cancer and Advances in Oncologic Therapy292
MP06-15 VIRTUAL REALITY IMMERSION FOR REDUCING ANXIETY AND PAIN DURING TRANSPERINEAL PROSTATE BIOPSY: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL264
MP27-09 OXYMATRINE IMPROVES ERECTILE FUNCTION THROUGH SUPPRESSION OF INFLAMMATION AND FIBROSIS IN DIABETIC RATS225
MP17-14 IDENTIFYING CRIBRIFORM PATTERN IN MPMRI SCANS FROM 3D RECONSTRUCTED RALP SPECIMENS USING DEEP LEARNING180
MP40-03 CIRCULATING CHROMOSOME CONFORMATION SIGNATURES ENHANCE THE ACCURACY OF PSA FOR DETECTING PROSTATE CANCER - RESULTS FROM PERFORMANCE OF THE EPISWITCH TM PCA T158
MP22-04 MAINTENANCE OF SKELETAL MUSCLES WHEN RECEIVING NEOADJUVANT CHEMOTHERAPY IMPROVES THE PROGNOSIS FOR PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER152
PD33-08 BACTERIAL BIOFILMS FROM INDWELLING SACRAL NEUROMODULATION DEVICES ARE RECONSTITUTABLE IN VITRO AND EXHIBIT DIFFERENTIAL FORMATION BY MATERIAL TYPE150
V02-10 LIMITED RESOURCES IMPROVISED BASKETS FOR PCNL139
MP67-12 FIRST LOOK: LASER SPECKLE IMAGING IS A NOVEL METHOD TO IDENTIFY AND PRESERVE NEUROVASCULAR BUNDLE DURING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY130
PD23-04 URINARY PROTEINS IN THE DIAGNOSIS OF MIXED INTRINSIC SPHINCTER DEFICIENCY AND DETRUSOR OVERACTIVITY IN FEMALE PATIENTS WITH STRESS URINARY INCONTINENCE?126
PD32-07 RACE MODIFIED ESTIMATED GLOMERULAR FILTRATION RATE UNDERESTIMATES CHRONIC KIDNEY DISEASE PREVALENCE IN AFRICAN-AMERICAN PATIENTS UNDERGOING PARTIAL AND RADICAL NEPHRECTOMY: IMPLICATIONS FOR SU105
MP64-20 UNDERSTANDING CLINICAL OUTCOMES IN PATIENTS RENDERED NO EVIDENCE OF DISEASE IN METASTATIC RENAL CELL CARCINOMA102
PD12-11 URETHRAL COMPLICATIONS AFTER METOIDIOPLASTY WITH URETHRAL RECONSTRUCTION90
PD27-02  99m TC-PSMA RADIOGUIDED SURGERY USING A DROP-IN GAMMA PROBE IN RADICAL PROSTATECTOMY: INITIAL RESULTS80
PD08-12 PREDICTORS OF PROGRESSION AND DELAYED INTERVENTION IN SMALL RENAL MASS PATIENTS UNDERGOING ACTIVE SURVEILLANCE WITHOUT HEALTH-RELATED SELECTION BIAS75
V04-06 ROBOTIC ASSISTED TRANS-VESICOSCOPIC URETERIC REIMPLANTATION IN CHILDREN: SURGICAL ERGONOMICS RELATED TO MUSCULOSKELETAL SYMPTOMS74
MP53-20 INITIAL UROLOGIC EVALUATION FOR ANORECTAL MALFORMATIONS: A PCPLC RETROSPECTIVE71
MP28-03 CYTOREDUCTIVE NEPHRECTOMY FOLLOWING IMMUNE CHECKPOINT INHIBITORS IS SAFE AND FACILITATES TREATMENT FREE INTERVALS69
V07-07 WIRE-GUIDED EXTRAVESICAL ROBOT-ASSISTED BLADDER DIVERTICULECTOMY AND Y-V PLASTY FOR RECURRENT BLADDER NECK STRICTURE67
PD04-08 BALIXAFORTIDE, A CXCR4 INHIBITOR, SYNERGIZES WITH DOCETAXEL TO DIMINISH TUMOR GROWTH IN A PROSTATE CANCER MODEL OF BONE METASTASIS65
LBA01-08 EFFICACY OF TARGETED MAST CELL INHIBITION THERAPY IN CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME65
PD43-02 FUNCTIONAL OUTCOMES AFTER SELECTIVE CLAMPING IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY64
MP48-04 PERSPECTIVES OF SOCIETY OF WOMEN IN UROLOGY MEMBERS TOWARD DOBBS V. JACKSON WOMEN′S HEALTH ORGANIZATION63
MP38-19 FOCAL THERAPY CANDIDACY: AN EVALUATION OF INITIAL AND CONTINUED ELIGIBILITY FOR FOCAL THERAPY IN AN ACTIVE SURVEILLANCE COHORT62
MP66-14 WEBSITE TRANSPARENCY AND INFORMATION DISSEMINATION AMONG UROLOGY RESIDENCY PROGRAMS61
PD17-03 REDOX IMBALANCE AND MAPK ACTIVATION MEDIATES PNEUMOPERITONEUM-INDUCED KIDNEY INJURY DURING MINIMALLY INVASIVE SURGERY52
PD39-07 CAN WE STOP DOING SYSTEMATIC BIOPSIES IN MEN WITH PIRADS/LIKERT 5 LESIONS ON MULTI PARAMETRIC MAGNETIC RESONANCE IMAGING? AN ANALYSIS FROM A MULTICENTRE PROSPECTIVE DATASET OF OVER 800 PATIENT52
MP57-02 AN UPDATE ON PROFESSIONAL BURNOUT AND CONFLICT-WORK FROM THE AUA WORKFORCE WORKGROUP48
HF02-04 KEEPING IT REEL: PHOTOGRAPHY AND CINEMATOGRAPHY IN UROLOGY46
PD24-03 BEST TREATMENT FOR OLIGOMETASTATIC RENAL CANCER: A QUASI-INDIVIDUAL PATIENT DATA ANALYSIS44
MP12-03 IMPLICATIONS OF RACE FREE RENAL FUNCTION EQUATIONS ON BLACK PATIENTS WITH RENAL CELL CARCINOMA44
MP30-02 A NOVEL PREDICTION MODEL FOR POSSIBILITY OF SPERM RETRIEVAL IN MICRO TESE FOR NON-OBSTRUCTIVE AZOOSPERMIA PATIENTS USING AUTOMATED ARTIFICIAL INTELLIGENCE42
MP62-05 AUA RECOMMENDED ANTIBIOTIC PROPHYLAXIS FOR PRIMARY PENILE IMPLANTATION RESULTS IN A HIGHER, NOT LOWER, RISK FOR POST-OPERATIVE INFECTION: A MULTICENTER ANALYSIS41
MP36-05 CLINIC SCORE - A NOVEL PREDICTION MODEL OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM OUTCOMES IN MEN WITH PEYRONIE’S DISEASE41
MP70-07 HIGH-PERFORMING SCALABLE EXTRACTION OF ELEMENTS OF URINARY TRACT DILATION CLASSIFICATION USING NATURAL LANGUAGE PROCESSING ALGORITHMS FOR NEONATAL ULTRASOUND REPORTS41
PD19-09 IMMUNOPROPHYLAXIS WITH AUTOVACCINE DECREASES HOSPITAL ADMISSIONS AND EMERGENCY ROOM VISITS IN PATIENTS WITH NEUROGENIC BLADDER40
MP36-04 PREDICTORS OF PENILE PLICATION AFTER INTRALESIONAL COLLAGENASE CLOSTRIDIUM HISTOLYTICUM INJECTION IN MEN WITH PEYRONIE’S DISEASE40
PD14-12 SEXUAL FUNCTION IN WOMEN FOLLOWING TENSION-FREE VAGINAL TAPE-OBTURATOR PROCEDURE: A PROSPECTIVE STUDY39
MP02-03 FASCIOCUTANEOUS FLAP CLOSURE OF THE PERINEUM AS AN ALTERNATIVE TO SCROTOPLASTY FOR EXTENSIVE GENITAL TISSUE LOSS39
MP41-18 CLINICAL MANIFESTATIONS OF BIRT-HOGG-DUBE SYNDROME IN A LARGE CLINICAL COHORT37
PD31-09 DEVELOPMENT OF EXTREME GRADIENT BOOST (XGBOOST) MACHINE LEARNING MODEL USING AN INSTITUTIONAL PEDIATRIC KIDNEY TRANSPLANT DATABASE FOR PREDICTION OF DELAYED GRAFT FUNCTION36
MP33-08 OPIOID PRESCRIBING PATTERNS AND POST-PROSTATECTOMY READMISSION35
PD47-12 DOES ANESTHESIA TYPE MATTER IN SHOCKWAVE LITHOTRIPSY?35
PD51-08 SREBP1 INDUCES RESISTANCE TO HIF-2α ANTAGONIST IN CLEAR CELL RENAL CELL CARCINOMA35
MP38-07 UPGRADING ON PER PROTOCOL VS FOR CAUSE SURVEILLANCE PROSTATE BIOPSIES: AN OPPORTUNITY TO DECREASING THE BURDEN OF ACTIVE SURVEILLANCE35
MP15-18 MOLECULAR CHARACTERIZATION OF URETHRAL CANCER AND COMPARISON WITH BLADDER CANCER34
Editorial Comment33
MP57-13 IS BIPOLAR ENUCLEATION OF THE PROSTATE AN EFFECTIVE AND COST-EFFICIENT ALTERNATIVE TO ROBOTIC SIMPLE PROSTATECTOMY?33
PD35-04 OPEN VS. ROBOTIC-ASSISTED RECONSTRUCTION IN VESICOURETHRAL ANASTOMOTIC STENOSIS33
Reply by Authors33
Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology33
V02-06 A TECHNIQUE FOR COMBINED ROBOTIC SACROCOLPOPEXY AND VENTRAL MESH RECTOPEXY33
MP02-18 APPROPRIATENESS OF IMAGING FOR LOW-RISK PROSTATE CANCER – REAL WORLD DATA FROM THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATION (PURC)32
MP01-10 THE LANDSCAPE OF RACIAL AND ETHNIC DISPARITY IN TESTICULAR CANCER STAGE PRESENTATION: A NATIONAL HOSPITAL-BASED STUDY30
MP76-14 PROPHYLACTIC DIPS AND IRRIGATION SOLUTIONS CAN CONSIDERABLY ALTER THE ANTIMICROBIAL EFFICACY OF INFLATABLE PENILE PROSTHESIS HYDROPHILIC SURFACE COATINGS29
PD23-09 THE EFFECT OF ADRENALECTOMY ON OVERALL SURVIVAL IN METASTATIC ADRENOCORTICAL CARCINOMA29
PD47-07 THE STUDY OF AUTOMATIC RECOGNITION OF STONE COMPONENTS USING DIGITAL IMAGES FROM INTRAOPERATIVE FLEXIBLE URETEROSCOPY29
MP24-16 URETEROSCOPY AT AMBULATORY SURGERY CENTERS CAN BE SAFE FOR CAREFULLY SELECTED HIGH-RISK PATIENTS29
PD58-09 GROWTH KINETICS OF ONCOCYTIC NEOPLASMS ON ACTIVE SURVEILLANCE AND IMPACT ON RENAL FUNCTION29
MP62-13 LONG-TERM MEDICATION USE AFTER SURGICAL TREATMENT FOR BLADDER OUTLET OBSTRUCTION, HOW DOES HOLEP COMPARE TO OTHER SURGICAL MODALITIES?29
PD61-05 ONCOLOGICAL OUTCOMES OF NEOADJUVANT DEGARELIX WITH APALUTAMIDE (ARNEO TRIAL) VERSUS STANDARD OF CARE PRIOR TO RADICAL PROSTATECTOMY FOR HIGH-RISK PROSTATE CANCER: A PROPENSITY SCORE MATCHED AN29
MP02-01 "DOCTOR 1 PUT ME IN TOUCH WITH A FORMER PATIENT... OF MY EXPERIENCE THROUGH IT, I THINK SHE HELPED ME THE MOST": PEER SUPPORT AS AN INVALUABLE RESOURCE IN THE SETTING OF BLADDER CANCER SURGERY28
MP32-17 LONG-TERM FOLLOW-UP AND SUCCESS RATE OF VENTRAL INLAY BUCCAL MUCOSAL GRAFT URETHROPLASTY VS DORSAL ONLAY BUCCAL MUCOSAL GRAFT URETHROPLASTY FOR FEMALE URETHRAL STRICTURE DISEASE28
MP34-14 ASSOCIATION OF POPULATION-LEVEL SOCIAL DETERMINANTS OF HEALTH WITH UROLOGIC CANCER CLINICAL TRIALS AVAILABILITY27
MP31-07 PROSTATE EXTRACELLULAR VESICLES AND PREDICTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A PROSPECTIVE SINGLE-INSTITUTION PILOT STUDY27
MP08-20 SIGNIFICANT DROP OF EARLY AND TWO-YR MORTALITY FOR BLADDER CANCER PATIENTS RECEIVING RADICAL CYSTECTOMY IN THE LAST 20 YEARS: SINGLE CENTER ANALYSIS27
PD14-08 IDENTIFICATION OF A BLADDER CANCER SUBPOPULATION THAT MAY BENEFIT FROM DASATINIB27
MP03-13 ARTIFICIAL URETHRAL SPHINCTER PRESSURE REGULATING BALLOON AND CUFF VARIATIONS FOLLOWING DEVICE EXPLANTATION26
PD55-09 THE BALL IS OUT OF OUR COURT: DOES MODERN PRIMARY CARE LITERATURE REFLECT THE AMERICAN UROLOGICAL ASSOCIATION CRYPTORCHIDISM GUIDELINES?26
MP76-02 EXPLORING THE EFFECTS OF AMNIOTIC BLADDER THERAPY ON FEMALE SEXUAL DYSFUNCTION IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME PATIENTS26
MP21-06 USABILITY TESTING OF THE SET BRAVE GOALS APP, A CONTINENCE GOAL-SELECTION APP FOR CHILDREN WITH SPINA BIFIDA26
MP35-13 PREVALENCE, TRENDS, AND COSTS OF OFFICE-BASED AND AMBULATORY SURGERY CENTER-BASED DIAGNOSTIC CYSTOSCOPY IN THE UNITED STATES26
PD49-07 UTILITY OF TESTICULAR SHEAR-WAVE ELASTOGRAPHY IN THE EVALUATION OF PEDIATRIC PATIENTS WITH KLINEFELTER SYNDROME25
MP36-11 GERIATRIC NUTRITIONAL RISK INDEX AS A SIGNIFICANT PROGNOSTIC FACTOR IN PATIENTS WITH CLEAR-CELL RENAL CELL CARCINOMA25
MP63-07 THE BUTOX STUDY: THE ROLE OF THE GUT MICROBIOME AND BUTYRATE IN CALCIUM OXALATE KIDNEY STONE DISEASE25
PD28-11 O TO ZZZ's: INVESTIGATING THE RELATIONSHIP BETWEEN ORGASM AND SLEEP QUALITY IN WOMEN25
MP70-20 MORTALITY DISPARITIES AMONG ASIAN AMERICANS DIAGNOSED WITH UROLOGIC CANCER25
MP44-05 PARENCHYMAL VOLUME ANALYSIS TO ASSESS LONGITUDINAL FUNCTIONAL DECLINE AND ATROPHY AFTER PN25
V11-11 HUGO RAS SIMPLE PROSTATECTOMY SEC. MILLIN: STEP BY STEP SURGICAL PROCEDURE AND SET UP IN A THREE ARMS CONFIGURATION25
PD61-12 SAME-DAY DISCHARGE FOLLOWING ROBOTIC PROSTATECTOMY: STANDARDIZATION AND SAFETY EVALUATION25
PD28-08 ASSOCIATION OF LOW TESTOSTERONE, FRAILTY, AND POSTOPERATIVE OUTCOMES AMONG MEN UNDERGOING UROLOGIC SURGERY24
PD27-01 DEVELOPMENT OF A MACHINE LEARNING (ML) MODEL TO AUTOMATICALLY AND PRECISELY IDENTIFY KIDNEY STONES FROM URETEROSCOPY VIDEO RECORDINGS24
MP19-05 LEARNING CURVES OF FUSION-GUIDED BIOPSY AND ULTRASOUND PROSTATE SEGMENTATION: A SINGLE-CENTER STUDY INVOLVING 14 OPERATORS AND 1721 PATIENTS24
PD31-06 LONG-TERM OUTCOMES AFTER ISOLATED EPISPADIAS REPAIR24
MP43-19 NOVEL NANOPARTICLE COATINGS DEMONSTRATE ANTIBACTERIAL AND ANTIBIOFILM PROPERTIES AGAINST MULTIPLE UROPATHOGENS23
PD52-01 A PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER TRIAL TO EVALUATE SAFETY AND EFFICACY OF PLATELET-RICH PLASMA INJECTIONS FOR PEYRONIE'S DISEASE: CLINICAL TRIAL UPDATE23
MP69-07 UROLOGIC COMPLICATIONS OF SODIUM-GLUCOSE CO-TRANSPORTER-2 (SGLT-2) INHIBITORS DIFFER BETWEEN DIABETIC MEN AND WOMEN22
MP54-17 FOSTERING DIVERSITY IN UROLOGY: ADDRESSING ETHNIC DISPARITIES IN APPLICANT AND RESIDENT RECRUITMENT22
PD33-09 PATHOLOGIC DOWN STAGING WITH NEOADJUVANT CHEMOTHERAPY AS A PREDICTOR OF ONCOLOGICAL OUTCOMES FOR UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY: A ROBUUST REGISTRY ANALYSIS22
PD14-10 ENHANCED ANTITUMOR EFFECT OF THE COMBINATION OF BACILLE CALMETTE-GUÉRIN AND AN IMMUNE CHECKPOINT INHIBITOR IN BLADDER CANCER-ON-A-CHIP22
MP69-05 DEVELOPING AN ANTIMICROBIAL IRRIGATION SOLUTION FOR ENDOUROLOGICAL PROCEDURES: EX VIVO EFFICACY AND IN VIVO SAFETY22
MP09-01 TEMPORAL TRENDS OF BPH MEDICATIONS AND PROCEDURES - CONTEMPORARY MEDICARE DATABASE ANALYSIS FROM 2013-202022
MP26-04 HOW MIRABEGRON AFFECTS THE HUMAN URETER: AN IN VITRO STUDY22
PD33-10 ROBOT-ASSISTED PARTIAL NEPHRECTOMY WITH HUGO™ RAS SYSTEM: PERIOPERATIVE OUTCOMES AND TRIFECTA ACHIEVEMENT FROM THE LARGEST MULTICENTRIC SERIES21
PD18-04 SURVIVAL IS DRAMATICALLY IMPROVED FOR MRCC PATIENTS WITH SARCOMATOID FEATURES WHO ARE TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND IMMUNE CHECKPOINT INHIBITORS REGARDLESS OF TREATMENT SEQUENCE21
MP29-20 A PROSPECTIVE, SINGLE CENTER RANDOMISED CONTROLLED TRIAL COMPARING DUSTING AND FRAGMENTATION MODES OF THULIUM FIBER LASER IN RETROGRADE INTRARENAL SURGERY21
MP36-19 DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA21
MP39-14 EVALUATING THE CONTRIBUTION OF THE STANDARDIZED LETTER OF RECOMMENDATION TO A SUCCESSFUL MATCH IN UROLOGY RESIDENCY21
PD55-04 IS PERCUTANEOUS NEPHROLITHOTOMY EFFECTIVE AND SAFE IN INFANTS YOUNGER THAN 2 YEARS OLD? COMPARISON OF MINI AND STANDARD PERCUTANEOUS NEPHROLITHOTOMY?21
PD14-05 THE STROMA-RICH CONSENSUS BLADDER CANCER SUBTYPE CORRELATES WITH IMPROVED PROGNOSIS AFTER NEOADJUVANT IMMUNOTHERAPY AND RADICAL CYSTECTOMY21
PD18-09 THE ROLE OF CYTOREDUCTIVE NEPHRECTOMY IN CONTEMPORARY METASTATIC RENAL CELL CARCINOMA: AN OTHER-CAUSE MORTALITY MATCH POPULATION-BASED STUDY21
MP30-15 MACHINE LEARNING TO DISTINGUISH BENIGN AND MALIGNANT RENAL LESIONS BASED ON ROUTINE CT IMAGING20
PD05-03 REDUCING EMERGENCY ROOM VISITS THROUGH THE USE OF MULTI-LANGUAGE EDUCATIONAL PAMPHLETS AFTER URETEROSCOPY WITH URETERAL STENT PLACEMENT20
MP41-11 CIRCULATING MICRORNA PROFILING FOR PREDICTION OF ONCOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS FOLLOWING RADICAL PROSTATECTOMY20
MP18-02 DOES DEEP LEARNING RECONSTRUCTION IMPROVE URETERAL STONE DETECTION AND SUBJECTIVE IMAGE QUALITY IN THE CT IMAGES OF PATIENTS WITH METAL HARDWARE?20
V14-05 ARTIFICIAL INTELLIGENCE-BASED INTRAOPERATIVE GUIDANCE: DEMONSTRATION OF REAL-TIME SEGMENTATION AND FEATURE TRACKING IN ROBOTIC SURGERY20
MP75-17 EXAMINING THE RELATIONSHIP BETWEEN DIETARY INFLAMMATORY INDEX AND URINARY FLOW RATE: RESULTS FROM A NATIONWIDE STUDY19
V08-03 ENDOSCOPIC RESECTION OF AN ENTEROANASTOMOTIC TUMOR RECURRENCE AFTER RADICAL CYSTECTOMY: A NOVEL APPROACH USING BIPOLAR RESECTION19
MP70-06 MATCHED ANALYSIS OF URINARY TRACT INFECTIONS AND READMISSIONS AFTER OPEN URETERONEOCYSTOSTOMY: DOES AGE MATTER?19
MP47-03 TRENDS IN SBRT FOR INOPERABLE RENAL CELL CARCINOMA19
MP15-10 DISCOVERY OF TBK1 ASSOCIATED ONCOGENIC MECHANISM WHICH MEDIATES THE UPPER-TRACT UROTHELIAL CARCINOMA WITH PREEXISTING END STAGE RENAL DISEASE19
PD41-11 THE IMPACT OF PROSTATE VOLUMES (≤80 CC VS. > 80 CC) ON PERIOPERATIVE OUTCOMES AND RISK OF RETREATMENT IN PATIENTS UNDERGOING AQUABLATION: A SINGLE-CENTER STUDY19
MP79-10 PHARMACOVIGILANCE ANALYSIS OF MELANOMA ADVERSE EVENTS IN MEN TREATED WITH SILDENAFIL FOR ERECTILE DYSFUNCTION19
MP46-13 ROBOT-ASSISTED RADICAL CYSTECTOMY WITH INTRACORPOREAL PADUA ILEAL NEOBLADDER: LONG-TERM FUNCTIONAL OUTCOMES AND CONTINENCE PREDICTORS ASSESSMENT FROM A HIGH-VOLUME CENTER LARGE CONSECUTIVE SER19
PD30-07 HIGH-GRADE TA NON-MUSCLE INVASIVE BLADDER CANCER DEMONSTRATES HOMOGENEOUS ONCOLOGICAL OUTCOMES REGARDLESS OF EAU 2021 RISK GROUP STRATIFICATION19
MP49-07 DEFINING HIGH GLEASON SCORE PROSTATE CANCER BY PROSTATE FLUID METABOLIC FINGERPRINT BASED MULTI-MODAL DIAGNOSIS19
PD15-04 PREDICTION OF PROSTATE CANCER SPECIFIC MORTALITY IN MEN UNDERGOING RADIOTHERAPY WITH OR WITHOUT HORMONAL TREATMENT, RISK STRATIFICATION BASED ON CLINICAL CHARACTERISTICS AND PSA TREATMENT RESP19
MP72-09 SELF-SCHEDULING IMPROVES QUALITY OF CARE FOR HOSPITAL DISCHARGE FOLLOW UP OF URINARY RETENTION PATIENTS19
PD08-11 ACTIVE SURVEILLANCE VERSUS PRIMARY INTERVENTION FOR CLINICAL T1a KIDNEY TUMORS: TWELVE-YEAR EXPERIENCE OF THE DISSRM PROSPECTIVE COMPARATIVE STUDY18
MP72-17 SURGEON’S PERSONAL OPIOID BEHAVIORS IMPACT POST-OPERATIVE PRESCRIBING FOR OUTPATIENT PROCEDURES18
MP44-08 RELATIONSHIP BETWEEN COVID 19 VACCINATION AND PSA LEVEL18
PD25-05 CHRONIC EXPOSURE OF PHYSIOLOGICAL CONCENTRATION OF ARSENIC INDUCED BLADDER MALIGNANCY IN PRECLINICAL MODELS18
MP35-11 TRENDS AND INCIDENCE OF REPORTED EVENTS ASSOCIATED WITH URETERAL STENTS: AN ANALYSIS OF THE FOOD AND DRUG ADMINISTRATION'S MANUFACTURER AND USER FACILITY DEVICE EXPERIENCE DATABASE18
MP05-01 MICRO COMPUTED TOMOGRAPHY ANALYSIS OF MINERAL IN RENAL PAPILLAE SHOWS THAT RANDALL'S PLAQUE FORMATION OCCURS INDEPENDENTLY OF UPSTREAM DUCTAL PLUGGING IN THE MEDULLA18
MP25-06 DEVELOPMENT OF A MULTI-INSTITUTIONAL, SIMULATION-BASED SURGICAL SKILLS BOOTCAMP FOR JUNIOR UROLOGY RESIDENTS18
MP61-11 RETZIUS-SPARING ROBOT-ASSISTED RADICAL PROSTATECTOMY AFTER PREVIOUS TRANS-URETHRAL RESECTION OF THE PROSTATE: ASSESSMENT OF FUNCTIONAL AND ONCOLOGICAL OUTCOMES18
MP71-18 PERIPHERAL TIBIAL NERVE STIMULATION DEMONSTRATES LIMITED IMPROVEMENT IN SELF-REPORTED SYMPTOMS FOR PATIENTS WITH OVERACTIVE BLADDER: SINGLE CENTER EXPERIENCE18
PD10-10 IMPROVING PREDICTION OF LOCAL STAGE BY PSMA-PET. DEVELOPMENT OF A NOVEL INTEGRATED TOOL FOR EXTRACAPSULAR EXTENSION AND SEMINAL VESICLE INVASION COMBINING CLINICAL AND IMAGING FEATURES IN LOCA18
PD45-03 FACTORS AFFECTING HOLMIUM LASER INEFFICIENCY: COMPARISON OF LARYNGEAL MASK AIRWAY AND ENDOTRACHEAL TUBE USE DURING FLEXIBLE URETEROSCOPY FOR RENAL STONES17
MP58-04 PROPOSAL AND INTERNAL VALIDATION OF A NOMOGRAM FOR THE PREDICTION OF LOCAL RECURRENCE FREE-SURVIVAL AFTER PERCUTANEOUS ABLATION FOR CT1 RENAL MASSES17
MP03-19 ROLE OF MICROFIBRILLAR-ASSOCIATED PROTEIN 4 IN PARTIAL BLADDER OUTFLOW OBSTRUCTION-RELATED BLADDER FIBROSIS17
MP74-18 DETRUSOR VOIDING CONTRACTION VELOCITY IS RELEVANT TO PATIENTS WITHOUT BLADDER OUTFLOW OBSTRUCTION17
MP06-20 SIGNIFICANT REDUCTION OF PERIOPERATIVE SERIOUS REPORTABLE EVENTS THROUGH A NOVEL SURGICAL SAFETY CHECKLIST AND TIME-OUT PROCEDURE17
MP75-10 SURVIVAL OUTCOMES BY RACE FOLLOWING MINIMALLY INVASIVE SURGICAL TREATMENT FOR UPPER TRACT UROTHELIAL CARCINOMA: AN ANALYSIS OF THE ROBUUST REGISTRY17
MP53-05 RISK OF ACUTE KIDNEY INJURY AFTER LOWER URINARY TRACT RECONSTRUCTION WITH EARLY NSAID THERAPY: A PROPENSITY MATCHED RETROSPECTIVE ANALYSIS17
MP15-09 TADALAFIL VERSUS COMBINED TAMSOLUSIN AND CIPROFLOXACIN FOR TREATMENT OF CHRONIC PELVIC PAIN SYNDROME: A RANDOMIZED CONTROLLED TRIAL17
LBA02-12 IS LEARNING CURVE IMPORTANT WHILE PERFORMING PSMA-PET? ANALYSIS OF DETECTION RATE ACCORDING TO GLEASON SCORE AND PSA LEVEL IN TWO TIMEFRAMES AT A BRAZILIAN HIGH-VOLUME CENTER17
PD24-07 FIRST ANALYSIS OF THE SAFETY AND EFFICACY OF UGN-101 IN THE TREATMENT OF URETERAL TUMORS17
HF02-14 HERNIAS, HEALING, HAGIOGRAPHY: AN ANALYSIS OF ST. ARTEMIOS AND BYZANTINE INCUBATION RITUALS16
Hooman Djaladat, MD, MS16
Benign Prostatic Hyperplasia: Epidemiology, Evaluation & Medical Non-surgical Therapy (MP24)16
Pro: Does COVID Affect Male Reproductive Health?16
Prostate Cancer: Markers I (MP41)16
Reply by Authors16
MP09-16 INFORMING AN APPROACH TO THE SUBCAPSULAR RENAL HEMATOMA (SRH): A TEN-YEAR REVIEW OF THE NATURAL HISTORY AND PROGRESSION OF SRH16
Bladder Cancer: Non-invasive III (MP15)16
Prostate Cancer: Detection & Screening I (MP40)15
Benign Prostatic Hyperplasia: Surgical Therapy & New Technology II (PD08)15
Health Services Research: Practice Patterns, Quality of Life and Shared Decision Making II (MP09)15
Benign Prostatic Hyperplasia: Surgical Therapy & New Technology III (IP19)15
Stone Disease: Basic Research & Pathophysiology (MP63)15
Prostate Cancer: Localized: Active Surveillance (MP38)15
Infertility: Epidemiology & Evaluation II (PD18)15
Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Non-neurogenic Voiding Dysfunction I (MP74)15
Surgical Technology & Simulation: Instrumentation & Technology (IP11)15
Bladder Cancer: Invasive VI (MP77)15
Editorial Comment15
Stone Disease: Surgical Therapy (Including ESWL) I (PD01)15
Editorial Comment14
Editorial Comment14
Male and Female Sexual Function and Dysfunction; Andrology14
This Month in Adult Urology14
Is Confirmatory Biopsy Still Necessary for Active Surveillance of Men With Grade Group 1 Prostate Cancer in the Era of Multiparametric MRI?14
Editorial Comment14
Male Infertility14
IP23-07 ANATOMY OF A COMPLICATION: CLINICO-RADIOLOGIC FEATURES OF BLEEDINGS AFTER ROBOTIC-ASSISTED RADICAL PROSTATECTOMY. THE ROLE OF THE OBTURATOR ARTERY VARIANTS14
Size Matters, at Least Sometimes…14
Imaging14
Editorial Comment14
Reply by Authors14
Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology14
Imaging Mass Cytometry Immune Profiling of Hunner Lesions in a Convenience Sample of Patients With Interstitial Cystitis/Bladder Pain Syndrome14
PD36-05 DEEP LEARNING PREDICTIVE MODEL FOR PROSTATE CANCER RECURRENCE USING CLINICAL AND HISTOLOGICAL DATA FROM THE TCGA DATABASE14
Editorial Comment14
Editorial Comment14
Socioeconomic Factors, Urological Epidemiology, and Practice Patterns14
Editorial Comment14
Editorial Comment14
Precision-guidance vs Systematic Sampling: Optimizing Biopsy Assessment of Secondary Prostate Cancer Suspicious Multiparametric Magnetic Resonance Imaging Lesions14
Urologic Heterodoxy Leads to Discovery14
MP20-07 NPTX1 IS A NOVEL SERUM BIOMARKER INDUCED BY ARPI TREATED PROSTATE CANCER AND ENRICHED IN LINEAGE PLASTICITY WITH BRN2 HIGH14
V15-06 SURGICAL MANAGEMENT OF TRAUMATIC INJURY IN A PEDIATRIC DUPLICATED COLLECTING SYSTEM13
Benign Prostatic Hyperplasia13
Editorial Comment13
IP27-04 PROSPECTIVE COTRIMS (COLOGNE TRIAL OF RETROPERITONEAL LYMPHADECTOMY IN METASTASTIC SEMINOMA) TRIAL – FINAL RESULTS13
PD32-10 AUTOMATED NEPHROMETRY SCORES THROUGH DIRECT PREDICTION OF EACH COMPONENT13
HF02-20 UROLOGY’S 20TH CENTURY BATTLE: SECURING ITS PLACE IN THE CLINIC AND CURRICULUM13
IP27-02 THE ROLE OF SQUAMOUS CELL CARCINOMA ANTIGEN AND INFLAMMATORY MARKERS IN THE PROGNOSIS OF PENILE SQUAMOUS CELL CARCINOMA13
MP11-02 RESULTS FROM THE CLEAR RCT SUGGEST FACTORS CORRESPONDING TO EARLY PATIENT SATISFACTION ARE BETTER FOLLOWING UROLIFT PUL VS. REZUM WVTT13
IP09-06 CLINICAL SIGNIFICANCE AND PROGNOSIS OF LOWER POLE HYDRONEPHROSIS FOLLOWING PROXIMAL URETEROURETEROSTOMY IN PEDIATRIC PATIENTS WITH DUPLEX SYSTEM13
Editorial Comment13
Letter: Treatment of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer with UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monother13
MP11-19 MEN WITH DIAGNOSED HAIR LOSS ON FIVE-ALPHA REDUCTASE INHIBITORS DO NOT HAVE DECREASED INCIDENCE OF BENIGN PROSTATIC HYPERPLASIA OR PROSTATE CANCER OVER A 20-YEAR PERIOD13
V12-03 ROBOT ASSISTED URETEROPLASTY USING VESICAL MUCOSA GRAFT: OUR INITIAL EXPERIENCE13
IP14-06 TUMOROID AND GENOMIC MODELING OF LOW GRADE INTERMEDIATE RISK BLADDER CANCER TO PREDICT INTRAVESICAL CHEMOTHERAPY RESPONSE13
PD32-11 PREOPERATIVE PREDICTORS OF ADVERSE PATHOLOGY AND RECURRENCE-FREE SURVIVAL FOR PATIENTS WITH RENAL MASSES13
IP09-15 MANDATORY RESEARCH YEAR IN PEDIATRIC UROLOGY FELLOWSHIP TRAINING: PERCEPTIONS OF THE CURRENT WORKFORCE13
PD39-05 NEUROMODULATION OF PELVIC NERVES INCREASES NERVE REGENERATION AFTER INJURY13
Reply: Efficacy and Safety of TAS-303 in Female Patients With Stress Urinary Incontinence: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial13
IP23-11 IMPACT OF ASPIRIN INTAKE ON BIOCHEMICAL RECURRENCE RATES IN HIGH-RISK PATIENTS FOLLOWING ROBOT-ASSISTED RADICAL PROSTATECTOMY: A MULTICENTER RETROSPECTIVE COHORT STUDY13
MP15-01 SEX-BASED DIFFERENCES OF SOMATIC MUTATIONS IN CAUCASIAN BLADDER CANCER POPULATION13
PD08-01 GLOBAL AQUABLATION EXPERIENCE FROM THE ICARUS (INTERNATIONAL COLLABORATIVE AQUABLATION RESEARCH UROLOGY SOCIETY) DATABASE: LARGEST COHORT ASSESSING EFFICACY AND SAFETY IN BENIGN PROSTATIC HYPE13
IP17-31 INITIAL EXPERIENCE OF 10 CASES WITH NOVEL EXTRA-PERITONEAL MULTIPORT ROBOT-ASSISTED KIDNEY TRANSPLANT (eRAKT): A PROPENSITY-MATCHED COMPARISON WITH THE TRANSPERITONEAL APPROACH13
IP03-39 BENEFITS OF HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) OVER TRANSURETHRAL RESECTION (TURP) FOR BLADDER OUTLET OBSTRUCTION (BOO) IN PATIENTS WITH PROSTATE CANCER: A PROPENSITY SCORE-MATC12
IP18-06 INFECTION FOLLOWING INFLATABLE PENILE PROSTHESIS PLACEMENT: A REAL-WORLD COMPARISON OF DEVICE SELECTION AND PATIENT CHARACTERISTICS12
PD06-01 INNOVATIVE BIOMARKERS: SERUM ANDROSTENEDIONE AND STEROID RATIOS AS PREDICTORS OF SPERM RETRIEVAL IN NON-OBSTRUCTIVE AZOOSPERMIA12
V10-04 A MODIFIED TECHNIQUE FOR DOUBLE DISTAL CORPORAL ANCHORING STITCH IN THE MANAGEMENT OF LATERAL PENILE PROSTHESIS CYLINDER EXTRUSION12
PD26-11 RENAL MASS BIOPSY FOR SMALL RENAL MASSES: A SINGLE-CENTER 20-YEAR EXPERIENCE12
IP08-28 CLINICAL OUTCOMES COMPARING MINI VERSUS STANDARD TUBELESS PERCUTANEOUS NEPHROLITHOTOMY: A MULTI-INSTITUTIONAL RANDOMIZED CONTROLLED TRIAL FROM THE EDGE CONSORTIUM12
MP26-06 DOES IT REALLY MATTER? OUTCOMES OF SCROTAL EXPLORATION FOR TESTICULAR TORSION PERFORMED BY PEDIATRIC UROLOGISTS VS. ADULT UROLOGISTS12
GG03-16 COMPARATIVE ANALYSIS OF PROSTATE VOLUME MEASUREMENT METHODS FOR PSA DENSITY: DEEP LEARNING-BASED AUTOSEGMENTATION IN MR/TRUS FUSION TARGETED PROSTATE BIOPSY12
IP07-26 CORRELATION BETWEEN MAYO ADHESIVE PROBABILITY SCORE (MAP) AND SURGICAL OUTCOMES IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY12
IP10-18 DOES KIDNEY TRANSPLANTATION IMPROVE ERECTILE FUNCTION? A PROSPECTIVE COHORT ANALYSIS OF END-STAGE RENAL DISEASE PATIENTS PRE AND POST KIDNEY TRANSPLANTATION IN MEXICO12
IP27-24 OSTEOPOROSIS AMONGST TESTICULAR CANCER SURVIVORS: LONG TERM FOLLOW-UP OF THE VETERANS AFFAIRS HEALTH SYSTEM12
MP37-18 IS IT WORTH USING THE COMPREHENSIVE COMPLICATION INDEX OVER THE CLAVIEN-DINDO CLASSIFICATION IN ELDERLY PATIENTS WHO UNDERWENT PERCUTANEOUS NEPHROLITHOTOMY?12
MP14-15 IMPACT OF CYTOREDUCTIVE NEPHRECTOMY AND TIMING OF SYSTEMIC THERAPY ON OVERALL SURVIVAL IN METASTATIC NON-CLEAR CELL RENAL CELL CARCINOMA12
IP20-22 BEYOND THE CONVENTIONAL APPROACH: PREPROCEDURAL CAUDAL VS. POSTPROCEDURAL PENILE BLOCKS FOR PEDIATRIC UROLOGIC SURGERY PAIN MANAGEMENT IN PENILE SURGERIES12
IP10-19 EXPLORING THE PREVALENCE OF POLYCYTHEMIA AMONG MEN IN TESTOSTERONE THERAPY12
IP27-40 CARE EXPERIENCE AND SUPPORT NEEDS OF TESTICULAR CANCER SURVIVORS: A QUALITATIVE STUDY12
IP27-31 EFFICACY OF TRIPLE TRACER TECHNIQUE (TC 99 RADIOCOLLOID, INDOCYANINE GREEN, AND BLUE DYE) VERSUS DUAL DYE TECHNIQUE (INDOCYANINE GREEN, METHYLENE BLUE) FOR SENTINEL NODE BIOPSY IN CLINICALLY N12
PD08-02 LONG-TERM OUTCOMES OF AQUABLATION FOR BENIGN PROSTATIC HYPERPLASIA: WATER, WATER II, OPEN WATER, FRANCAIS WATER, AND JAPAN PMS STUDIES12
V04-08 BREAKING BARRIERS IN ROBOTIC SURGERY: THE EFFICIENCY AND SAFETY OF LOW-COST, SINGLE-PORT EXTRAPERITONEAL SINGLE PORT ROBOTIC ASSISTED RADICAL PROSTATECTOMY12
IP14-07 THERMOSENSITIVE LIPOSOMAL DOXORUBICIN COMBINED WITH HYPERTHERMIC INTRAVESICAL CHEMOTHERAPY FOR TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER12
IP20-02 HOW BLADDER EXSTROPHY AFFECTS MOTHERS' QUALITY OF LIFE, RESILIENCE, AND MENTAL HEALTH: A COMPARISON OF SINGLE-CHILD AND MULTIPLE-CHILD FAMILIES12
IP06-27 ANALYSIS OF GENETIC TESTING IN KIDNEY STONE DISEASE: A SINGLE-INSTITUTIONAL ANALYSIS12
PD38-09 NEDD4-MEDIATED UBIQUITINATION OF GPX4: A KEY PATHWAY IN HIGH GLUCOSE-INDUCED FERROPTOSIS IN CORPUS CAVERNOSUM SMOOTH MUSCLE CELLS12
V10-06 A NOVEL TECHNIQUE FOR DIRECT VISUALIZATION OF INFLATABLE PENILE PROSTHESIS RESERVOIR PLACEMENT USING A SINGLE-INCISION PENOSCROTAL APPROACH12
PD39-09 SNM LEAD SENSING: SACRAL EVOKED RESPONSES ACROSS STANDARD THERAPY PROGRAMS12
UCF-13 ENDOUROLOGIC NEEDS ASSESSMENT TOOL: EVALUATING GLOBAL NEEDS AND BARRIERS FOR ENDOSCOPIC UROLOGICAL PROCEDURES12
MP28-10 IMPACT OF CYTOREDUCTIVE NEPHRECTOMY ON IMMUNE CHECKPOINT INHIBITOR THERAPY: TREATMENT OUTCOMES OF IMMUNE INHIBITORS COMBINATION THERAPIES FOR METASTATIC RENAL CELL CARCINOMA WITH PRIMARY KIDNE12
V02-12 PSYCHOGENIC URINARY INCONTINENCE: DA VINCI XI ROBOT-ASSISTED HEMINEPHROURETERECTOMY FOR COMPLETE DUPLEX KIDNEY WITH ECTOPIC URETERAL DRAINAGE12
PD08-10 COLLECTIVE OPTILUME BPH 2-YEAR CLINICAL OUTCOMES: COMBINED EXPERIENCE FROM THE PIVOTAL PINNACLE AND EVEREST PROSPECTIVE CLINICAL STUDIES12
MP24-08 BODY ROUNDNESS INDEX, A NOVEL OBESITY METRIC, AND ITS RELATIONSHIP WITH STRESS URINARY INCONTINENCE IN A POPULATION-BASED COHORT12
PD21-04 COMPARATIVE ANALYSIS OF LEARNING CURVES IN ENDOSCOPIC PROSTATE RESECTION AND ENUCLEATION WITH LASER DURING UROLOGY RESIDENCY: IS ENDOSCOPIC PROSTATE ENUCLEATION TRAINING EXCLUSIVE FOR EXPERTS?12
MP37-03 HIGH DEDUCTIBLE HEALTH PLAN ENROLLMENT SIGNIFICANTLY DECREASES PROSTATE CANCER SCREENING12
GG02-28 UTILITY OF FRAILTY IN PREDICTING SEVERE ADVERSE EVENTS IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER TREATED WITH UPFRONT DOCETAXEL OR DAROLUTAMIDE PLUS DOCETAXEL: A MULTICENTER RETROSPECTIV11
IP11-23 URETERAL TISSUE TEMPERATURE WITH HO:YAG LASER ACTIVATION DURING URETEROSCOPY IN AN IN-VIVO PORCINE MODEL11
Our Ongoing Evolution of Peer Review11
IP26-33 THE IMPACT OF ANDROGEN DEPRIVATION THERAPY ON LOWER URINARY TRACT SYMPTOMS IN PROSTATE CANCER PATIENTS11
MP05-08 A NOVEL URODYNAMIC SCORING SYSTEM FOR EVALUATING CONTINENCE QUALITY OUTCOMES OF TOTALLY INTRACORPOREAL ROBOTIC ORTHOTOPIC ILEAL NEOBLADDERS AT MID-TERM FOLLOW-UP: RESULTS OF A PROSPECTIVE MULT11
PD37-07 CONSOLIDATIVE SURGERY FOR ADVANCED UROTHELIAL CARCINOMA FOLLOWING INDUCTION ENFORTUMAB VEDOTIN AND/OR IMMUNE CHECKPOINT INHIBITOR THERAPY: A MULTICENTER ANALYSIS11
IP26-14 THERAPEUTIC TARGETING OF ARHGEF2 -RAC1 SIGNALING FOR NEUROENDOCRINE PROSTATE CANCER11
MP17-20 COMPARISON OF CLINICAL CHARACTERISTICS BETWEEN VON HIPPEL-LINDAU SYNDROME PATIENTS WITH MONOGENIC AND POLYGENIC MUTATIONS: A RETROSPECTIVE ANALYSIS BASED ON NEXT-GENERATION SEQUENCING RESULTS 11
Reply by Authors11
MP23-14 ALTERNATIVE TO EMERGENCY DEPARTMENT FOR THE AFTER-HOURS CARE OF URGENT UROLOGIC ISSUES IN ESTABLISHED PATIENTS11
IP16-40 PATHOLOGIC FINDINGS AMONG RENAL MASSES IN SOLID ORGAN TRANSPLANT PATIENTS11
0.14244985580444